You are here

Article Text

Article menu
Download PDFPDF
Joint Pathology and Endoscopy Section Symposium Including the Basil Morson Lecture: Optical Diagosis vs. Histopathology in Upper GI Disease
PTU-038 Predictors of adenoma detection at colonoscopy after bowel scope surveillance
  1. K Siau1,2,
  2. AC Yew3,
  3. S Shetty1,
  4. S Ishaq1,
  5. S Jewes4,
  6. MJ Brookes3,
  7. BC McKaig3,
  8. A Veitch3,
  9. A Murugananthan3
  1. 1Department of Gastroenterology, Dudley Group Hospitals NHS Foundation Trust, Dudley
  2. 2JAG Quality Assurance Department, Royal College of Physicians, London
  3. 3Department of Gastroenterology
  4. 4Bowel Cancer Screening, Royal Wolverhampton NHS Trust, Wolverhampton, UK

Abstract

Introduction Flexible sigmoidoscopy (bowel scope) reduced colorectal cancer incidence and mortality in a population aged 55–64.[1]Patients progressed to colonoscopy based on ‘high risk’ features (Table 1).[1] Based on these pivotal findings, the UK bowel scope (BS) surveillance programme was introduced in 2013 to individuals aged 55. The Wolverhampton bowel cancer screening centre was the first UK site to fully roll out the programme. The correlation between BS findings and subsequent colonoscopy has not previously been evaluated in this specific cohort.

Method We prospectively collated data from all BS patients at our centre and identified those undergoing colonoscopy between August 2013–2016. We assessed conversion rates, compliance with BS protocol and correlated endoscopic and histological findings to identify predictors for detection of pathology at colonoscopy. Univariate analysis was performed using Pearson’s chi2.

View this table:

Results 11 711 bowel scopes were performed, with an adenoma detection rate (ADR) of 8.5%, and conversion to colonoscopy in 421 patients (3.6%). 386 were included for analysis after excluding incomplete colonoscopy/histology. All patients were aged 55 (64.8% male). Additional ADR at colonoscopy was 35.2%, with malignant diagnoses in 1.5% (all detected at BS). The adenoma miss rate at BS was 5.2%. On univariate analysis (Table 1), polyp ≥10 mm was the only indication associated with increased ADR at colonoscopy (OR 2.13, p<0.001). Additional predictors identified included villous (not tubulovillous) histology (OR 4.41, p=0.02), and male gender (OR 2.35, p<0.001). These factors also significantly predicted new ≥10 mm adenoma. 57 (14.8%) underwent colonoscopy outside protocol, which reduced ADR (OR 0.29, p=0.03). After excluding high risk indications, changing the conversion criteria from any villous to villous only histology altered sensitivity from 27.2% to 83.3%, and specificity from 84.5% to 80.5%.

Conclusion At BS, male gender, ≥10 mm polyps, and villous histology are predictors of proximal colonic pathology. Further analyses are required to clarify the benefits of converting low-risk tubulovillous adenomas at BS to colonoscopy.

Reference

  1. . WS Atkin, Lancet2010;375:1624–33

Disclosure of Interest None Declared

  • adenoma
  • flexible sigmoidoscopy
  • Surveillance

https://doi.org/10.1136/gutjnl-2017-314472.133

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.